Published in Nature on August 29, 1991
IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. J Exp Med (2007) 1.75
Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. J Exp Med (1993) 1.73
Association between B-lymphocyte membrane immunoglobulin and multiple members of the Src family of protein tyrosine kinases. Mol Cell Biol (1992) 1.66
CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proc Natl Acad Sci U S A (1993) 1.60
Evidence for a preformed transducer complex organized by the B cell antigen receptor. Proc Natl Acad Sci U S A (1996) 1.60
EBF contains a novel zinc coordination motif and multiple dimerization and transcriptional activation domains. EMBO J (1995) 1.57
Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells. Nat Immunol (2009) 1.46
Analysis of Ig-alpha-tyrosine kinase interaction reveals two levels of binding specificity and tyrosine phosphorylated Ig-alpha stimulation of Fyn activity. EMBO J (1994) 1.43
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33
Dual role of the tyrosine activation motif of the Ig-alpha protein during signal transduction via the B cell antigen receptor. EMBO J (1994) 1.32
Oligomeric organization of the B-cell antigen receptor on resting cells. Nature (2010) 1.27
The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence. EMBO J (1996) 1.25
Two new proteins preferentially associated with membrane immunoglobulin D. EMBO J (1994) 1.25
Purification of early-B-cell factor and characterization of its DNA-binding specificity. Mol Cell Biol (1993) 1.24
BLyF, a novel cell-type- and stage-specific regulator of the B-lymphocyte gene mb-1. Mol Cell Biol (1992) 1.24
Induction of tolerance to an IgG autoantibody. Proc Natl Acad Sci U S A (1992) 1.19
The alpha/beta sheath and its cytoplasmic tyrosines are required for signaling by the B-cell antigen receptor but not for capping or for serine/threonine-kinase recruitment. Proc Natl Acad Sci U S A (1994) 1.18
A high-molecular-weight complex of membrane proteins BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum. Proc Natl Acad Sci U S A (2003) 1.17
Functional reconstitution of an immunoglobulin antigen receptor in T cells. J Exp Med (1992) 1.17
The B cell antigen receptor of class IgD induces a stronger and more prolonged protein tyrosine phosphorylation than that of class IgM. J Exp Med (1995) 1.11
The immunoglobulin (Ig)alpha and Igbeta cytoplasmic domains are independently sufficient to signal B cell maturation and activation in transgenic mice. J Exp Med (1997) 1.10
Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation. Proc Natl Acad Sci U S A (2010) 1.09
Multiple motifs regulate the B-cell-specific promoter of the B29 gene. Proc Natl Acad Sci U S A (1993) 1.06
A selective defect in IgM antigen receptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes. EMBO J (1994) 1.02
AID-induced remodeling of immunoglobulin genes and B cell fate. Oncotarget (2014) 1.02
Comparison of human B cell antigen receptor complexes: membrane-expressed forms of immunoglobulin (Ig)M, IgD, and IgG are associated with structurally related heterodimers. J Exp Med (1992) 1.01
Early function of Pax5 (BSAP) before the pre-B cell receptor stage of B lymphopoiesis. J Exp Med (1998) 1.00
Soluble CD23 controls IgE synthesis and homeostasis in human B cells. J Immunol (2012) 0.99
B29 gene products complex with immunoglobulins on B lymphocytes. Proc Natl Acad Sci U S A (1992) 0.98
The membrane IgM-associated proteins MB-1 and Ig-beta are sufficient to promote surface expression of a partially functional B-cell antigen receptor in a nonlymphoid cell line. Proc Natl Acad Sci U S A (1992) 0.97
Structural and functional studies of Igalphabeta and its assembly with the B cell antigen receptor. Structure (2010) 0.93
Immunoglobulin gamma 2b transgenes inhibit heavy chain gene rearrangement, but cannot promote B cell development. J Exp Med (1993) 0.89
Antigen endocytosis and presentation mediated by human membrane IgG1 in the absence of the Ig(alpha)/Ig(beta) dimer. EMBO J (1997) 0.89
Regulation of CD20 in rituximab-resistant cell lines and B-cell non-Hodgkin lymphoma. Clin Cancer Res (2012) 0.89
Ig alpha and Ig beta are functionally homologous to the signaling proteins of the T-cell receptor. Mol Cell Biol (1994) 0.88
Heterogeneity of immunoglobulin-associated molecules on human B cells identified by monoclonal antibodies. Proc Natl Acad Sci U S A (1992) 0.88
Models of signal transduction through the B-cell antigen receptor. Immunology (2003) 0.87
Targeting the extracellular membrane-proximal domain of membrane-bound IgE by passive immunization blocks IgE synthesis in vivo. J Immunol (2008) 0.85
Cellular signalling mechanisms in B lymphocytes. Biochem J (1993) 0.84
Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen. J Immunol (2010) 0.83
Silencer elements controlling the B29 (Igbeta) promoter are neither promoter- nor cell-type-specific. Proc Natl Acad Sci U S A (1997) 0.82
Membrane isoforms of human immunoglobulins of the A1 and A2 isotypes: structural and functional study. Immunology (1997) 0.81
B cell receptor accessory molecules in the channel catfish, Ictalurus punctatus. Dev Comp Immunol (2008) 0.81
Structure and expression of the mb-1 transcript in human lymphoid cells. Clin Exp Immunol (1992) 0.81
The two membrane isoforms of human IgE assemble into functionally distinct B cell antigen receptors. J Exp Med (1996) 0.80
IL-4 upregulates Igα and Igβ protein, resulting in augmented IgM maturation and B cell receptor-triggered B cell activation. J Immunol (2013) 0.79
Cytoplasmic Ig alpha serine/threonines fine-tune Ig alpha tyrosine phosphorylation and limit bone marrow plasma cell formation. J Immunol (2011) 0.78
Activation of the B cell receptor leads to increased membrane proximity of the Igα cytoplasmic domain. PLoS One (2013) 0.77
A Rapid Method to Characterize Mouse IgG Antibodies and Isolate Native Antigen Binding IgG B Cell Hybridomas. PLoS One (2015) 0.76
IL-4 rescues surface IgM expression in chronic lymphocytic leukemia. Blood (2016) 0.76
Deletion of the α immunoglobulin chain membrane-anchoring region reduces but does not abolish IgA secretion. Immunology (2012) 0.76
Regulation of B cell fate by chronic activity of the IgE B cell receptor. Elife (2016) 0.75
The nanoscale spatial organization of B cell receptors on IgM- and IgG-expressing human B cells. Mol Biol Cell (2016) 0.75
Surface expression of immunoglobulin isotypes on primary human B cells: no evidence for glycosyl-phosphatidylinositol linkage. Immunology (1993) 0.75
Molecular characterization of the CD79a and CD79b and its role against Aeromonas hydrophila infection in Chinese sucker (Myxocyprinus asiaticus). Fish Physiol Biochem (2017) 0.75
IgH isotype-specific B cell receptor expression influences B cell fate. Proc Natl Acad Sci U S A (2017) 0.75
Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (1989) 6.70
Mechanism of antigen-driven selection in germinal centres. Nature (1990) 5.26
Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence. Cell (1985) 4.38
Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature (1986) 4.19
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med (1987) 3.82
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene (2008) 3.79
Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (1991) 3.61
B cells acquire antigen from target cells after synapse formation. Nature (2001) 3.31
Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. Immunity (1998) 3.27
Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity (1998) 3.16
Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature (2001) 3.09
Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell (1994) 3.06
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Hyperresponsive B cells in CD22-deficient mice. Science (1996) 2.86
TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity (1998) 2.76
Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease). Histopathology (1991) 2.75
A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature (1985) 2.63
Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J (1999) 2.58
Variable region genes in the human T-cell rearranging gamma (TRG) locus: V-J junction and homology with the mouse genes. EMBO J (1988) 2.54
The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region. EMBO J (1989) 2.48
Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice. Nucleic Acids Res (1997) 2.44
Colorectal cancer pathology reporting: a regional audit. J Clin Pathol (1997) 2.41
Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg (2003) 2.40
Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc Natl Acad Sci U S A (1993) 2.30
Apoptosis: molecular regulation of cell death. Eur J Biochem (1996) 2.29
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry. Nature (1988) 2.28
Two transcriptional activators, CCAAT-box-binding transcription factor and heat shock transcription factor, interact with a human hsp70 gene promoter. Mol Cell Biol (1987) 2.17
Granulomatous inflammation--a review. J Clin Pathol (1983) 2.15
Activation of mouse complement by monoclonal mouse antibodies. Eur J Immunol (1981) 2.11
Somatic hypermutation. Curr Opin Immunol (1995) 2.08
Squamous carcinoma of the colorectum and its genesis. J Pathol (1979) 2.07
Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A (1998) 1.94
Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. Immunol Today (1993) 1.93
The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer (2002) 1.88
Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med (1999) 1.83
Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes. EMBO J (1991) 1.83
Regulation of membrane IgM expression in secretory B cells: translational and post-translational events. EMBO J (1987) 1.82
Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology (1999) 1.82
Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature (1995) 1.80
Both DNA strands of antibody genes are hypermutation targets. Proc Natl Acad Sci U S A (1998) 1.77
Recombinant antibodies possessing novel effector functions. Nature (1985) 1.76
Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol (1996) 1.72
Codon bias targets mutation. Nature (1995) 1.69
Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. Proc Natl Acad Sci U S A (2001) 1.69
A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus. Nature (1990) 1.65
Patterns of gastritis in patients with gastro-oesophageal reflux disease. Gut (1999) 1.63
Racial variation in the O-acetylation phenotype of human colonic mucosa. J Pathol (1994) 1.62
The intron requirement for immunoglobulin gene expression is dependent upon the promoter. Nucleic Acids Res (1988) 1.60
Detection of three protein binding sites in the serum-regulated promoter of the human gene encoding the 70-kDa heat shock protein. Proc Natl Acad Sci U S A (1987) 1.60
Antigen-induced apoptosis in developing T cells: a mechanism for negative selection of the T cell receptor repertoire. Eur J Immunol (1989) 1.58
The importance of the 3'-enhancer region in immunoglobulin kappa gene expression. Nucleic Acids Res (1990) 1.56
A stem cell niche theory of intestinal crypt maintenance based on a study of somatic mutation in colonic mucosa. Am J Pathol (1992) 1.56
Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment Pharmacol Ther (2000) 1.55
Disruption of mouse polymerase zeta (Rev3) leads to embryonic lethality and impairs blastocyst development in vitro. Curr Biol (2000) 1.54
Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology (1994) 1.53
Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta (2013) 1.50
The mouse IgH 3'-enhancer. Eur J Immunol (1991) 1.50
The British Society of Gastroenterology early gastric cancer/dysplasia survey: an interim report. Gut (1990) 1.49
Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med (2000) 1.49
Role of DNA breaks and ADP-ribosyl transferase activity in eukaryotic differentiation demonstrated in human lymphocytes. Nature (1982) 1.48
Switch from hapten-specific immunoglobulin M to immunoglobulin D secretion in a hybrid mouse cell line. Proc Natl Acad Sci U S A (1981) 1.48
Cells strongly expressing Ig(kappa) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers. EMBO J (1997) 1.46
Abdominal lymphoma--the place for surgery. J R Soc Med (1989) 1.42
Hemin-induced transcriptional activation of the HSP70 gene during erythroid maturation in K562 cells is due to a heat shock factor-mediated stress response. Mol Cell Biol (1989) 1.38
Expression and targeting of intracellular antibodies in mammalian cells. EMBO J (1990) 1.38
Purification and properties of Klebsiella aerogenes D-arabitol dehydrogenase. Biochem J (1979) 1.38
Association of CD22 with the B cell antigen receptor. Eur J Immunol (1993) 1.35
Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG)1 activity. J Exp Med (2000) 1.34
Metaplastic polyps and polyposis of the colorectum. Histopathology (1980) 1.31
B cells extract and present immobilized antigen: implications for affinity discrimination. EMBO J (2000) 1.31
The half-life of immunoglobulin mRNA increases during B-cell differentiation: a possible role for targeting to membrane-bound polysomes. Genes Dev (1988) 1.31
Reciprocal chromosome translocation between c-myc and immunoglobulin gamma 2b genes. Nature (1983) 1.31
Functional significance of an overlapping consensus binding motif for Sp1 and Zif268 in the murine adenosine deaminase gene promoter. Proc Natl Acad Sci U S A (1991) 1.31
Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J (1997) 1.30
Polymeric immunoglobulin M is secreted by transfectants of non-lymphoid cells in the absence of immunoglobulin J chain. EMBO J (1987) 1.30
The targeting of somatic hypermutation. Semin Immunol (1996) 1.29
Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87. Gut (1992) 1.26
Crypt restricted heterogeneity of goblet cell mucus glycoprotein in histologically normal human colonic mucosa: a potential marker of somatic mutation. Br J Cancer (1990) 1.25
The immunogenicity of chimeric antibodies. J Exp Med (1989) 1.25
Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol (1995) 1.23
The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer (1988) 1.19
The sequence of the mu transmembrane segment determines the tissue specificity of the transport of immunoglobulin M to the cell surface. J Exp Med (1990) 1.18
The alpha/beta sheath and its cytoplasmic tyrosines are required for signaling by the B-cell antigen receptor but not for capping or for serine/threonine-kinase recruitment. Proc Natl Acad Sci U S A (1994) 1.18
Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer (2004) 1.17
Somatic mutation of immunoglobulin lambda chains: a segment of the major intron hypermutates as much as the complementarity-determining regions. Proc Natl Acad Sci U S A (1994) 1.16
Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology (1988) 1.16